Astria Therapeutics, Inc. - 04635X102
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Vestal Point Capital, LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Ryan Wilder | 0.0% | 0 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Glazer Capital, LLC | 6.61% | 3,776,154 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | Paul J. Glazer | 6.61% | 3,776,154 | View |
| Feb 09, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Jan 28, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Dec 10, 2025 | SCHEDULE 13G | Glazer Capital, LLC | 5.53% | 3,155,200 | View |
| Dec 10, 2025 | SCHEDULE 13G | Paul J. Glazer | 5.53% | 3,155,200 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.